Overexpression of CDR1 and CDR2 genes plays an important role in fluconazole resistance in Candida albicans with G487T and T916C mutations

Journal of International Medical Research

Volumn 38, Issue 2, 2010, Pages 536-545

  Chen, L M ^a   Xu, Y H ^a   Zhou, C L ^a   Zhao, J ^a   Li, C Y ^a   Wang, R ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Azole resistance; Candida albicans; Fluconazole; Real time polymerase chain reaction

Indexed keywords

CANDIDA DRUG RESISTANCE 1; CANDIDA DRUG RESISTANCE 2; FLUCONAZOLE; FLUCONAZOLE RESISTANCE 1; FUNGAL PROTEIN; MICROORGANISM PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ANTIFUNGAL RESISTANCE; ARTICLE; BROTH DILUTION; CANDIDA ALBICANS; CONTROLLED STUDY; DISK DIFFUSION; DRUG DETERMINATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENOTYPE; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 77953721380     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001003800216     Document Type: Article

References (36)

1. Dixon DM, McNeil MM, Cohen ML, et al: Fungal infections: a growing threat. Public Health Rep 1996; 111: 226-235.
2. White TC, Marr KA, Bowden RA: Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Gin Microbiol Rev 1998; 11: 382-402.
3. Sanglard D, Odds FC: Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002; 2: 73-85.
4. Sanglard D, Ischer F, Koymans L, et al: Amino acid substitutions in the cytochrome P-450 lanosterol 14a-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents. Antlmicrob Agents Chemother 1998; 42: 241-253.
5. lia XM, Ma ZP, Jia Y, et al: RTA2, a novel gene involved in azole resistance in Candida albicans. Biochem Biophys Res Commun 2008; 373: 631-636.
6. Calabrese D, Bille J, Sanglard D: A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology 2000; 146: 2743-2754.
7. Chandra J, Kuhn DM, Mukherjee PK, et al: Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385-5394.
8. Maebashi K, Kudoh M, Nishiyama Y, et al: A novel mechanism of fluconazole resistance associated with fluconazole sequestration in Candida albicans isolates from a myelofibrosis patient. Microbiol Immunol 2002; 46: 317-326.
9. Xu Y, Chen L, Li C: Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERGll mutations. JAntimicrob Chemother 2008; 61: 798-804.
10. National Committee for Clinical Laboratory Standards (NCCLS): Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeast: Approved Standard, 2nd edn. Wayne, PA: NCCLS, 2002; Vol 28: p M27-A3.
11. National Committee for Clinical Laboratory Standards (NCCLS): Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline. Wayne, PA: NCCLS, 2004; Vol 29: p M44-A2.
12. McCullough MI, Clemons KV, Stevens DA: Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. ] Clln Microbiol 1999; 37: 417-421.
13. i4a method. Methods 2001; 25: 402-408.
14. Giulietti A, Overbergh L, Valckx D, et al An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 2001; 25: 386-401.
15. Morschhduser I, Barker KS, Liu TT, et al: The transcription factor Mrrlp controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog 2007; 3: el64.
16. O'Connor L, Lahiff S, Casey F, et al: Quantification of ALS1 gene expression in Candida albicans biofilms by RT-PCR using hybridisation probes on the LightCycler. Mol Cell Probes 2005; 19: 153-162.
17. Akbar DH, Tahawi AT: Candidemia at a University Hospital: epidemiology, risk factors and predictors of mortality. Ann Saudi Med 2001; 21: 178-182.
18. St-Germain G, Laverdiere M, Pelletier R, et al: Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada. J Gin Microbiol 2001; 39: 949-953.
19. Bedini A, Venturelli C, Mussini C, et al: Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital. Gin Microbiol Infect 2006; 12: 75-80.
20. Marichal P, Koymans L, Willemsens S, et al: Contribution of mutations in the cytochrome P450 14a-demethylase (Ergllp, Cyp51p) to azole resistance in Candida albicans. Microbiology 1999; 145: 2701-2713.
21. Podust LM, Poulos TL, Waterman MR: Crystal structure of cytochrome P450 14a-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci USA 2001; 98: 3068-3073.
22. Lamb DC, Kelly DE, Schunck WH, et al: The mutation T315A in Candida albicans sterol 14a-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity. J Biol Chem 1997; 272: 5682-5688.
23. Kelly SL, Lamb DC, Kelly DE: Y132H substitution in Candida albicans sterol 14a-demethylase confers fluconazole resistance by preventing binding to haem. FEMS Microbiol Lett 1999; 180: 171-175.
24. Kelly SL, Lamb DC, Loeffler I, et al: The G464S amino acid substitution in Candida albicans sterol 14a-demethylase causes fluconazole resistance in the clinic through reduced affinity. Biochem Biophys Res Commun 1999; 262: 174-179.
25. Lamb DC, Kelly DE, White TC, et al: The R467K amino acid substitution in Candida albicans sterol 14a-demethylase causes drug resistance through reduced affinity. Antimicrob Agents Chemother 2000; 44: 63-67.
26. Chen SH, Sheng CQ, Xu XH, et al Identification of Y118 amino acid residue in Candida albicans sterol 14a-demethylase associated with the enzyme activity and selective antifungal activity of azole analogues. Blot Pharm Bull 2007; 30: 1246-1253.
27. liang WS, Tan SS, Jiang GY, et al: Synergistic effect of terbinafine combined with fluconazole or itraconazole on stable fluconazole-resistant Candida albicans induced by fluconazole in Wfro. Chin J Microbiol Immunol 2006; 26: 360-364 [in Chinese].
28. Perea S, Lopez-Ribot JL, Kirkpatrick WR, et al: Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 2001; 45: 2676-2684.
29. Goldman GH, da Silva Ferreira ME, dos Reis Marques E, et al: Evaluation of fluconazole resistance mechanisms in Candida albicans clinical isolates from HIV-infected patients in Brazil. Diagn Microbiol Infect Dis 2004; 50: 25-32.
30. Ribeiro MA, Paula CR: Up-regulation of ERC11 gene among fluconazole-resistant Candida albicans generated in vitro: is there any clinical implication? Diagn Microbiol Infect Dis 2007; 57: 71-75.
31. White TC, Holleman S, Dy F, et al: Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 2002; 46: 1704-1713.
32. Morschhauser J: The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 2002; 1587: 240-248.
33. Holmes AR, Lin YH, Niimi K, et al: ABC transporter Cdrlp contributes more than Cdr2p does to fluconazole efflux in fluconazole-resistant Candida albicans clinical isolates. Antimicrob Agents Chemother 2008; 52: 3851-3862.
34. White TC: Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 1997; 41: 1482-1487.
35. Marr KA, Lyons CN, Rustad TR, et al: Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR. Antimicrob Agents Chemother 1998; 42: 2584-2589.
36. Lyons CN, White TC: Transcriptional analyses of antifungal drug resistance in Candida albicans. Antimicrob Agents Chemother 2000; 44: 2296-2303.